# Intrepida Bio

**Canonical:** https://apis.io/providers/intrepedia-bio/  
**APIs profiled:** 0

Intrepida Bio, Inc. is a preclinical biotechnology company (founded 2019, headquartered in Encinitas / San Diego, CA) developing medicines that modulate the innate immune system to fight cancer and other diseases. Working with Biouniversa s.r.l., the company holds worldwide rights to develop proprietary monoclonal antibodies against the novel targets BAG3 and its receptor IFITM-2 — a signaling axis tumors hijack to build a growth-promoting, immune-evasive microenvironment (notably in pancreatic ductal adenocarcinoma, PDAC). Intrepida raised roughly $9.5M from Canaan, Sofinnova, Indaco Venture Partners and Vertis to fund IND-enabling studies of its lead oncology program. It was surfaced as a portfolio company of canaan-partners and added to the API Evangelist network as a stub. NOTE: this is a therapeutics/drug-discovery company with no public API, developer portal, or software product surface; its website (intrepidabio.com) no longer resolves and the entity appears dormant/defunct, so no API artifacts apply.

## Kin Score — 5.0 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 5.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotechnology, Oncology, Immuno-Oncology, Innate Immunity, Monoclonal Antibodies, Cancer, Drug Discovery, Preclinical, Therapeutics

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/intrepedia-bio/). Scores are computed from the provider's own public artifacts under a published rubric.